Advertisement

Topics

Cambridge BioScience Ltd Company Profile

01:33 EST 15th December 2018 | BioPortfolio

Cambridge BioScience is a leading distributor of cutting edge life science research products. Our goal is to identify the most exciting new life science technologies and bring these to our customers, who work in all areas of biological research.

For our customers, we seek out new technologies that will advance their research and help them to make breakthrough discoveries. For our Partners we aim to bring their products to market as quickly and effectively as possible. Our business continues to evolve, both in the nature of the products we offer, as well in the ways we communicate with our customers.

Currently we are seeing the dramatic expansion of functional studies in the post-genome age. Our focus is on new technologies that can reveal the mechanisms underlying cellular processes and to make the link between genes, proteins and patients. In pharmaceutical research we are concentrating on methods that can help drug developers to make safer, more effective drugs that target the individual patient.

We’re also adapting quickly to new communication methods. Through this new website, along with a powerful new Customer Database, we aim to make your experience of working with us more personal. We want to understand your needs better and provide you with the information you need, when you need it and to adapt with you as your research evolves. Register on this site to make the most of the new approaches we are developing.

We always welcome opportunities to work with new Partners that have developed innovations which can benefit our customers. We are now increasingly working with supplier companies that can provide complex service based offerings and those seeking to reach a wider European audience with a single commercial partner. In particular we are targeting the Pharmaceutical Biotechnology and Diagnostics industries with this approach.

This year, for the first time, we are offering instrumentation that complements our reagent products. We would be interested to hear from manufacturers that have developed novel instrumentation systems that address complex biological challenges.

Your feedback is important to us, so please get in contact with us with your ideas as to how we can serve you better.

Location

Munro House, Trafalgar Way
Bar Hill
Cambridge
Cambridgeshire
CB23 8SQ
United Kingdom

Contact

Phone: +44 (0)1223 316 855
Fax: +44 (0)1954 781 323
Email: sales@bioscience.co.uk


News Articles [566 Associated News Articles listed on BioPortfolio]

Cambridge Bancorp Announces Record Quarterly Earnings and Declares Dividend

CAMBRIDGE, Mass., Oct. 15, 2018 /PRNewswire/ -- Cambridge Bancorp (NASDAQ: CATC) (the "Company"), the parent of Cambridge Trust Company, today announced unaudited net income of Read more...

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment PR Newswire London, August 5 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATIO...

Aytu BioScience, Inc.: Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / October 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant ...

Aytu BioScience, Inc.: Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / October 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant...

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $...

Aytu BioScience, Inc.: Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio

Company Posts Highest Ever Quarterly Revenue ENGLEWOOD, CO / ACCESSWIRE / November 7, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercializa...

Aytu BioScience, Inc.: Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018

ENGLEWOOD, CO / ACCESSWIRE / November 27, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significan...

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to ...

Cyclenium Pharma Inc.Helmut Thomas, Ph.D., DABT, +1-819-571-4296President, CEO & CSOhthomas@cyclenium.comorHaplogen Bioscience GmbHGeorg Casari, Ph.D., +43-1-9165522Chief Exec...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

O24 [Revive Bioscience, Inc.]

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

Polocaine [Dentsply Pharmaceutical]

3% Polocaine DENTAL (Mepivacaine Hydrochloride Injection, USP) 2% Polocaine DENTAL with Levonordefrin 1:20,000 (Mepivacaine Hydrochloride and Levonordefrin Injection, USP)

Idkit hp one [Exalenz Bioscience Ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

Xylocaine [Dentsply Pharmaceutical]

2% Xylocaine DENTAL with epinephrine 1:50,000 (Lidocaine HCl 2% and Epinephrine 1:50,000 Injection) 2% Xylocaine DENTAL with epinephrine 1:100,000 (Lidocaine HCl 2% and Epinephrine 1:100,000 Injection...

Clinical Trials [35 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Weight Loss for Obese Individuals With Gout

This study evaluates effect of weight loss in a group of obese patients with gouty arthritis. The study is a randomised group trial where half the patients receive intensive weight loss in...

PAN-study: Pan-Cancer Early Detection Study (PAN)

The PAN Cancer Early Detection study is a prospective cross-sectional observational case-control study evaluating whether Breath Biopsy (developed by Owlstone Medical Ltd.; the Sponsor of...

Color Vision as a Measure for Inherited Retinal Diseases

Background: - The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRD...

Mayo AVC Registry and BioBank

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death i...

Companies [708 Associated Companies listed on BioPortfolio]

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

Bioscience Bridge, LLC

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founde...

CURE

CURE is the educational and business support network organization for bioscience in Connecticut, with over 100 members. Its mission is to build networks and critical mass for the industry within the s...

More Information about "Cambridge BioScience Ltd" on BioPortfolio

We have published hundreds of Cambridge BioScience Ltd news stories on BioPortfolio along with dozens of Cambridge BioScience Ltd Clinical Trials and PubMed Articles about Cambridge BioScience Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge BioScience Ltd Companies in our database. You can also find out about relevant Cambridge BioScience Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record